Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London

Jeff Haas <jhaas@juniper.net> Tue, 16 August 2022 20:02 UTC

Return-Path: <jhaas@juniper.net>
X-Original-To: 114attendees@ietfa.amsl.com
Delivered-To: 114attendees@ietfa.amsl.com
Received: from localhost (localhost [127.0.0.1]) by ietfa.amsl.com (Postfix) with ESMTP id 42B17C1522AD for <114attendees@ietfa.amsl.com>; Tue, 16 Aug 2022 13:02:16 -0700 (PDT)
X-Virus-Scanned: amavisd-new at amsl.com
X-Spam-Flag: NO
X-Spam-Score: -3.377
X-Spam-Level:
X-Spam-Status: No, score=-3.377 tagged_above=-999 required=5 tests=[BAYES_00=-1.9, DKIMWL_WL_HIGH=-0.571, DKIM_SIGNED=0.1, DKIM_VALID=-0.1, DKIM_VALID_AU=-0.1, DKIM_VALID_EF=-0.1, RCVD_IN_DNSWL_LOW=-0.7, RCVD_IN_ZEN_BLOCKED_OPENDNS=0.001, SPF_HELO_NONE=0.001, SPF_PASS=-0.001, T_SCC_BODY_TEXT_LINE=-0.01, URIBL_BLOCKED=0.001, URIBL_DBL_BLOCKED_OPENDNS=0.001, URIBL_ZEN_BLOCKED_OPENDNS=0.001] autolearn=unavailable autolearn_force=no
Authentication-Results: ietfa.amsl.com (amavisd-new); dkim=pass (2048-bit key) header.d=juniper.net header.b=jPPfZgMi; dkim=pass (1024-bit key) header.d=juniper.net header.b=f+vQql7j
Received: from mail.ietf.org ([50.223.129.194]) by localhost (ietfa.amsl.com [127.0.0.1]) (amavisd-new, port 10024) with ESMTP id v0x1OGt-uXlI for <114attendees@ietfa.amsl.com>; Tue, 16 Aug 2022 13:02:11 -0700 (PDT)
Received: from mx0a-00273201.pphosted.com (mx0a-00273201.pphosted.com [208.84.65.16]) (using TLSv1.2 with cipher ECDHE-RSA-AES256-GCM-SHA384 (256/256 bits)) (No client certificate requested) by ietfa.amsl.com (Postfix) with ESMTPS id 43FC2C1522AE for <114attendees@ietf.org>; Tue, 16 Aug 2022 13:02:10 -0700 (PDT)
Received: from pps.filterd (m0108158.ppops.net [127.0.0.1]) by mx0a-00273201.pphosted.com (8.17.1.5/8.17.1.5) with ESMTP id 27GEq3Ji022199; Tue, 16 Aug 2022 13:02:08 -0700
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=juniper.net; h=from : to : cc : subject : date : message-id : references : in-reply-to : content-type : content-id : content-transfer-encoding : mime-version; s=PPS1017; bh=kwgVFwXnynS7pqJPapR+dj8p6rmyUlaLlLZZYSJZN8Y=; b=jPPfZgMiiCy458Q9LdzOhTYEIGjmgXEimSc0DkDPa1b1qXjIbsqCDzEmo6gpuiEG2+jZ WLYEXYqg9pAaMN9meJvKYZTd/3zIgSp/CzuLpSqdbUeRvQhWHY+imVp7xh5B/oX1iTkn zKnV+byg2S0p57iWlwpJMFfixUUsdc29+JZMoKhjzW9by41rScY7AYizzhlR1qSx/P4m wU/y0LFhUG4Vh/247SE+asQX+Ym/yt9YAPIyaKGNQGE0iGIMNuY4yjNgYovHBgCfdGg1 Yqef07wGWNbnSg5cKxFdMnijpOywZ/gTCOlIEhaHgTy/VTl1SDj62u8RiivkrJlXuBqJ Jw==
Received: from na01-obe.outbound.protection.outlook.com (mail-eastusazlp17010004.outbound.protection.outlook.com [40.93.11.4]) by mx0a-00273201.pphosted.com (PPS) with ESMTPS id 3j0dcg0ju5-1 (version=TLSv1.2 cipher=ECDHE-RSA-AES256-GCM-SHA384 bits=256 verify=NOT); Tue, 16 Aug 2022 13:02:08 -0700
ARC-Seal: i=1; a=rsa-sha256; s=arcselector9901; d=microsoft.com; cv=none; b=azgs6CtnMA6gJCoVlqdU5OQc07hOqbAQ2T0Bf39WF1DipG90kS7nZ37wgEx3p6Y5LT/FrmhaQhLmQ0+iYY6VlvyXar2N7/lakp55bkXDfBeDQaNm3N1dqtZ9w3w6dHErzGsdu3Wd2qoth42T5Z74618O9Cowu4oFkMe7Q8NjfvRgMwiNPdaZe6FdKAV4pAYg5VcdqUahWfnkEL1gqzJ0sN1tDRG74gIKC7bGvAND3KHO04JmbwAct6ZwEbh66mbZXVzPNWzoENNJyudUWEpqpp5CM9D2fHjNoBNTBalRr4BerD/BGEbRjZkDtLy2Bo6AEqvthaAaXZGmDRDnI1algw==
ARC-Message-Signature: i=1; a=rsa-sha256; c=relaxed/relaxed; d=microsoft.com; s=arcselector9901; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-AntiSpam-MessageData-ChunkCount:X-MS-Exchange-AntiSpam-MessageData-0:X-MS-Exchange-AntiSpam-MessageData-1; bh=kwgVFwXnynS7pqJPapR+dj8p6rmyUlaLlLZZYSJZN8Y=; b=FV4sAdzAMWMKvUWEJdI506AxKU5sKD7se8an1GAxAH8SeSWDgKa+p8fwCMOcU+1R0TCy/MVW+QMfk6E2Rln+s854EUIY8dHHcb0f/MFci5m0C3mkxLj0e1kVEcHrIa1uSeJ/3AAZu+2Mgc4fc30qY/ZL7wbrT31fDrCXG24+72nflDswl/9JQ9SfhEp1mUmY9ZNQdvrxLEY3EuDSN8zc6OEYjDwVHaWhEOZQe6I360LtH7/zoTezhcjy5M5HE+4y0w++Jiaq+iDTzoQ2Ct4qKdRaqwQil7ttlbndi0zPJgphu0U8p+oG6kndx57JmPn3MT6/k38JLBaKE+i9RWAX3Q==
ARC-Authentication-Results: i=1; mx.microsoft.com 1; spf=pass smtp.mailfrom=juniper.net; dmarc=pass action=none header.from=juniper.net; dkim=pass header.d=juniper.net; arc=none
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=juniper.net; s=selector1; h=From:Date:Subject:Message-ID:Content-Type:MIME-Version:X-MS-Exchange-SenderADCheck; bh=kwgVFwXnynS7pqJPapR+dj8p6rmyUlaLlLZZYSJZN8Y=; b=f+vQql7jgrxXmwOoiTg49Nxzz/7yrkrSzz2LDgxrab3PQfnKnXlCFDbM9UJpRyoY2kjjt4p6lbaLzXHMxH3Bz3ruDZ09pgFuWgru4npLPRXgDPJXLCcv3AZegLz9PiM+36YmkvBQgku3ZG6yg8OSTpOxBqXViip5f2GcoRESih4=
Received: from BYAPR05MB6053.namprd05.prod.outlook.com (2603:10b6:a03:d6::12) by BYAPR05MB4696.namprd05.prod.outlook.com (2603:10b6:a03:42::16) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.20.5525.10; Tue, 16 Aug 2022 20:02:04 +0000
Received: from BYAPR05MB6053.namprd05.prod.outlook.com ([fe80::a143:76af:3c8d:b71f]) by BYAPR05MB6053.namprd05.prod.outlook.com ([fe80::a143:76af:3c8d:b71f%7]) with mapi id 15.20.5525.011; Tue, 16 Aug 2022 20:02:04 +0000
From: Jeff Haas <jhaas@juniper.net>
To: Personal Sam Smith <sam@samuelsmith.org>
CC: "Salz, Rich" <rsalz=40akamai.com@dmarc.ietf.org>, Ted Lemon <mellon@fugue.com>, "114attendees@ietf.org" <114attendees@ietf.org>
Thread-Topic: [114attendees] [114all] Consultation on COVID management for IETF 115 London
Thread-Index: AQHYsaLf9jzSCPuQJkeETor1J8/OR62xpV2AgABLToD//78dAA==
Date: Tue, 16 Aug 2022 20:02:04 +0000
Message-ID: <5E47FBC2-54E9-4F86-8C96-682F594FB693@juniper.net>
References: <4B348C11-79CE-4E7E-9DFD-B5CE79224767@ietf.org> <2F1594AF-4729-4908-918E-CD2151639E23@samuelsmith.org> <9c06d39e-0a03-916f-89e3-eff9ed2231bf@petit-huguenin.org> <CF6F11B2-6E3D-45FD-B520-29FE7DA52658@live555.com> <df828417-9229-4f67-93bf-9de9202e1950@petit-huguenin.org> <LO0P123MB660168369A86618248E627B5A9679@LO0P123MB6601.GBRP123.PROD.OUTLOOK.COM> <CAMOjQcFkuBWOGPCwP=UFbodA15R79COvncHw-nm1YmFFoL1N+w@mail.gmail.com> <6aa68882-60bb-4a7c-ad84-51c58f7bd78a@evequefou.be> <B53FD62C-6AFD-4048-823E-F723A14C207B@gmail.com> <9e5b5853-2f5b-e5ab-19da-562f8a099b7b@joelhalpern.com> <CAPt1N1kiuq6PnQUkKbqekdhoJ-s8EXiUAOyYKt3ekZ94vNokyg@mail.gmail.com> <CAC8QAce=5fqe-cEtqT1Zp23HwdB1-fhA585YEpBTDowQBrDyEw@mail.gmail.com> <CAPt1N1=MkgpF7d65_NGGZkwB9AVHcC7jKBDeEymGRcna=RY2hw@mail.gmail.com> <F3FF62DC-7038-489E-9842-3A696F67EF5E@akamai.com> <E546BCBE-376D-4B92-8CA5-D8297BC07E78@samuelsmith.org> <9156173E-B1F5-4A95-BC72-1E9399673AFB@juniper.net> <86673B65-6C4B-4398-BFC3-5C7CDB797D06@samuelsmith.org>
In-Reply-To: <86673B65-6C4B-4398-BFC3-5C7CDB797D06@samuelsmith.org>
Accept-Language: en-US
Content-Language: en-US
X-MS-Has-Attach:
X-MS-TNEF-Correlator:
user-agent: Microsoft-MacOutlook/16.63.22070801
msip_labels: MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_Enabled=true; MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_ContentBits=0; MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_SiteId=bea78b3c-4cdb-4130-854a-1d193232e5f4; MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_ActionId=7a97020f-cd99-4e71-80fd-cfeb54a67e99; MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_SetDate=2022-08-16T20:01:27Z; MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_Method=Standard; MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_Name=Juniper Business Use Only;MSIP_Label_0633b888-ae0d-4341-a75f-06e04137d755_Enabled=true;
x-ms-publictraffictype: Email
x-ms-office365-filtering-correlation-id: d07f42c7-6561-40cd-9235-08da7fc230eb
x-ms-traffictypediagnostic: BYAPR05MB4696:EE_
x-ms-exchange-senderadcheck: 1
x-ms-exchange-antispam-relay: 0
x-microsoft-antispam: BCL:0;
x-microsoft-antispam-message-info: 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
x-forefront-antispam-report: CIP:255.255.255.255; CTRY:; LANG:en; SCL:1; SRV:; IPV:NLI; SFV:NSPM; H:BYAPR05MB6053.namprd05.prod.outlook.com; PTR:; CAT:NONE; SFS:(13230016)(4636009)(376002)(346002)(39860400002)(396003)(136003)(366004)(8676002)(6512007)(4326008)(38070700005)(66446008)(76116006)(122000001)(64756008)(6506007)(66556008)(91956017)(316002)(71200400001)(53546011)(6486002)(478600001)(38100700002)(83380400001)(41300700001)(66476007)(33656002)(54906003)(36756003)(66946007)(2906002)(186003)(66574015)(966005)(2616005)(5660300002)(6916009)(8936002)(86362001)(45980500001); DIR:OUT; SFP:1102;
x-ms-exchange-antispam-messagedata-chunkcount: 1
x-ms-exchange-antispam-messagedata-0: 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
Content-Type: text/plain; charset="utf-8"
Content-ID: <B9D9CCB441D0DC4C9375A3F1446C7B76@namprd05.prod.outlook.com>
Content-Transfer-Encoding: base64
MIME-Version: 1.0
X-OriginatorOrg: juniper.net
X-MS-Exchange-CrossTenant-AuthAs: Internal
X-MS-Exchange-CrossTenant-AuthSource: BYAPR05MB6053.namprd05.prod.outlook.com
X-MS-Exchange-CrossTenant-Network-Message-Id: d07f42c7-6561-40cd-9235-08da7fc230eb
X-MS-Exchange-CrossTenant-originalarrivaltime: 16 Aug 2022 20:02:04.7161 (UTC)
X-MS-Exchange-CrossTenant-fromentityheader: Hosted
X-MS-Exchange-CrossTenant-id: bea78b3c-4cdb-4130-854a-1d193232e5f4
X-MS-Exchange-CrossTenant-mailboxtype: HOSTED
X-MS-Exchange-CrossTenant-userprincipalname: mnlimcy+m/kff+fyJ9G140vudx0o57QEd99ohFihqMGFl6uqujDhDoE9iBgCcv1SVuh6Qbx/lyOzZeZE6aW1lg==
X-MS-Exchange-Transport-CrossTenantHeadersStamped: BYAPR05MB4696
X-Proofpoint-ORIG-GUID: 8uegmpuaRT-Zu1dCD1iglOahED_vpO30
X-Proofpoint-GUID: 8uegmpuaRT-Zu1dCD1iglOahED_vpO30
X-Proofpoint-Virus-Version: vendor=baseguard engine=ICAP:2.0.205,Aquarius:18.0.883,Hydra:6.0.517,FMLib:17.11.122.1 definitions=2022-08-16_08,2022-08-16_02,2022-06-22_01
X-Proofpoint-Spam-Details: rule=outbound_spam_notspam policy=outbound_spam score=0 priorityscore=1501 clxscore=1015 mlxscore=0 spamscore=0 phishscore=0 mlxlogscore=999 impostorscore=0 malwarescore=0 adultscore=0 suspectscore=0 lowpriorityscore=0 bulkscore=0 classifier=spam adjust=0 reason=mlx scancount=1 engine=8.12.0-2207270000 definitions=main-2208160074
Archived-At: <https://mailarchive.ietf.org/arch/msg/114attendees/NFp48tlsi7voLMQjDKlsn9jly9w>
Subject: Re: [114attendees] [114all] Consultation on COVID management for IETF 115 London
X-BeenThere: 114attendees@ietf.org
X-Mailman-Version: 2.1.39
Precedence: list
List-Id: Mailing list for IETF 114 attendees <114attendees.ietf.org>
List-Unsubscribe: <https://www.ietf.org/mailman/options/114attendees>, <mailto:114attendees-request@ietf.org?subject=unsubscribe>
List-Archive: <https://mailarchive.ietf.org/arch/browse/114attendees/>
List-Post: <mailto:114attendees@ietf.org>
List-Help: <mailto:114attendees-request@ietf.org?subject=help>
List-Subscribe: <https://www.ietf.org/mailman/listinfo/114attendees>, <mailto:114attendees-request@ietf.org?subject=subscribe>
X-List-Received-Date: Tue, 16 Aug 2022 20:02:16 -0000

You clearly didn't note that the cited URL was updated August 11, 2022... same as your other materials.

-- Jeff (not sure why he's bothering.)


On 8/16/22, 3:54 PM, "Personal Sam Smith" <sam@samuelsmith.org> wrote:

    [External Email. Be cautious of content]


    I believe that the August 2022 "Summary of Guidance for Minimizing the Impact of COVID-19 on Individual Persons, Communities, and Health Care Systems — United States, August 2022" Supercedes earlier now outdated guidance by the CDC from 2019. Which is now quite ancient in Covid terms.

    For those who find it inconvenient to read the full 9-page report, the summary guidance at the top of the report is quite easy to understand.



    "
    Summary
    What is already known about this topic?

    High levels of immunity and availability of effective COVID-19 prevention and management tools have reduced the risk for medically significant illness and death.

    What is added by this report?

    To prevent medically significant COVID-19 illness and death, persons must understand their risk, take steps to protect themselves and others with vaccines, therapeutics, and nonpharmaceutical interventions when needed, receive testing and wear masks when exposed, receive testing if symptomatic, and isolate for ≥5 days if infected.

    What are the implications for public health practice?

    Medically significant illness, death, and health care system strain can be reduced through vaccination and therapeutics to prevent severe illness, complemented by use of multiple prevention methods to reduce exposure risk and an emphasis on protecting persons at high risk for severe illness.
    "


    I believe is not inaccurate to assert that many of the comments in this thread represent now outdated views on the scientific understanding of Covid and public health policy with regards Covid.

    Notably, I might add, is the recognition now by many respected prominent epidemiologists (which apparently includes those at the CDC) that Covid has transitioned to an endemic phase dominated by escape mutant varieties. While vaccines are one highly recommended prophylactic mechanism to reduce the severity of symptoms in the event of infection, (as the CDC guidelines recognize, they are not the only mechanism therapeutics and prior infection are also recognized mechanisms. And as the report details vaccination is contraindicated in some circumstances.

    Science is always adapting to new information, and the members of the IETF community would be well served to do the same.



    > On 16 Aug 2022, at 13:24 , Jeff Haas <jhaas@juniper.net> wrote:
    >
    > Since you're wanting to wave around the CDC pages, you forgot to add:
    > https://urldefense.com/v3/__https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html__;!!NEt6yMaO-gk!D_NNwqUqE0fPgMBzMlkK5BqRwhlBp9Kh1jSLGTecVpxBlAAEHuB_F5coSjqr74SnqicMhCnUZei0VA$
    >
    > For their community level high:
    > When the COVID-19 Community Level is High:
    >
    >    Wear a high-quality mask or respirator.
    >    If you are at high risk of getting very sick, consider avoiding non-essential indoor activities in public where you could be exposed.
    >
    > Currently, roughly 1/3 of US counties are High.
    >
    > The direct metric won't carry through to the UK, but as you say... different recommendations.
    >
    > -- Jeff (who had to cancel vacation due to COVID acquired during IETF and related travel)
    >
    > On 8/16/22, 3:03 PM, "114attendees on behalf of Personal Sam Smith" <114attendees-bounces@ietf.org on behalf of sam@samuelsmith.org> wrote:
    >
    >    [External Email. Be cautious of content]
    >
    >
    >    Because the next meeting is not in the USA, CDC guidance is not binding, but it may be informative to know that as of August 11, 2022. The CDC substantially changed its recommended procedures for dealing with Covid. Some of the changes are in direct response to the preponderance of research reports that have been accumulating over the last few months.
    >
    >    https://urldefense.com/v3/__https://www.cdc.gov/mmwr/volumes/71/wr/mm7133e1.htm?s_cid=mm7133e1_w__;!!NEt6yMaO-gk!BbusBsndexJIGRxHz95bGVmARzQt9ioaKkDwpB9i36Ye-y-BTq4nTkXrOVxc25s9den9Yd6aESnNBw$
    >
    >
    >    Some notable changes:  (Direct quotes from the CDC guidelines are bracketed with "".
    >
    >    “As SARS-CoV-2, the virus that causes COVID-19, continues to circulate globally, high levels of vaccine- and infection-induced immunity and the availability of effective treatments and prevention tools have substantially reduced the risk for medically significant COVID-19 illness (severe acute illness and post-COVID-19 conditions) and associated hospitalization and death. These circumstances now allow public health efforts to minimize the individual and societal health impacts of COVID-19 by focusing on sustainable measures to further
    >
    >    reduce medically significant illness as well as to minimize strain on the health care system, while reducing barriers to social, educational, and economic activity.”
    >
    >
    >    Note the change in focus that now prioritizes reducing barriers to activity except for medically significant (aka severe) illness.
    >
    >
    >    “All persons should seek testing for active infection when they are symptomatic or if they have a known or suspected exposure to someone with COVID-19,”
    >
    >
    >    Note the change from blanket testing to now only when symptomatic or after known contact with symptomatic.
    >
    >
    >    “CDC now recommends case investigation and contact tracing only in health care settings and certain high-risk congregate settings.”
    >
    >
    >    Note the change from blanket track and trace to now only track and trace in high-risk settings (i.e elderly).
    >
    >    “CDC’s COVID-19 prevention recommendations no longer differentiate based on a person’s vaccination status because
    >    breakthrough infections occur, though they are generally mild, and persons who have had COVID-19 but are not vaccinated have some degree of protection against severe illness from their previous infection.”
    >
    >
    >    Note that vaccination status is no longer a recommended prevention measure for transmission and infection control. It would seem that IETF's policy of requiring mandatory vaccination for admittance is no longer advisable.
    >
    >
    >
    >
    >> On 16 Aug 2022, at 09:44 , Salz, Rich <rsalz=40akamai.com@dmarc.ietf.org> wrote:
    >>
    >>> I was pointing out that if we are /not/ doing online-only, then necessarily we have accepted as true the conjecture that meeting in person adds significant value. And that being the case, the metric for what policy to have for in-person meetings should not be "how many people will be infected with this policy" but rather "how many people will come with this policy."
    >>
    >> I fully agree.
    >>
    >> (It’d be nice if people trimmed duplicate signatures :)
    >> --
    >> 114attendees mailing list
    >> 114attendees@ietf.org
    >> https://urldefense.com/v3/__https://www.ietf.org/mailman/listinfo/114attendees__;!!NEt6yMaO-gk!BbusBsndexJIGRxHz95bGVmARzQt9ioaKkDwpB9i36Ye-y-BTq4nTkXrOVxc25s9den9Yd6g5dEYnQ$
    >
    >    --
    >    114attendees mailing list
    >    114attendees@ietf.org
    >    https://urldefense.com/v3/__https://www.ietf.org/mailman/listinfo/114attendees__;!!NEt6yMaO-gk!BbusBsndexJIGRxHz95bGVmARzQt9ioaKkDwpB9i36Ye-y-BTq4nTkXrOVxc25s9den9Yd6g5dEYnQ$
    >
    >
    > Juniper Business Use Only



Juniper Business Use Only